Loading the map…
Other human health activities · Milton Keynes, Buckinghamshire
Solvotrin Therapeutics (UK)
Solvotrin Therapeutics (UK) Limited
Private limited company registered in Milton Keynes, classed under “Other human health activities”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024* | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
6 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-26
- AccountsTotal exemption full accounts made up to 31 December 2025
- AccountsTotal exemption full accounts made up to 31 December 2024
- AccountsTotal exemption full accounts made up to 31 December 2023
- AccountsTotal exemption full accounts made up to 31 December 2022
- AccountsCurrent accounting period extended from 31 October 2022 to 31 December 2022
- AccountsAccounts for a dormant company made up to 31 October 2021
- FilingResolutions
- FilingMemorandum and Articles of Association
- DirectorsAppointment of Mr Ian Yates as a director on 23 May 2022
- AccountsAccounts for a dormant company made up to 31 October 2020
- AccountsTotal exemption full accounts made up to 31 October 2019
- IncorporationIncorporation
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Solvotrin Therapeutics (UK) do?
Private limited company registered in Milton Keynes, classed under “Other human health activities”.
›How much turnover does Solvotrin Therapeutics (UK) make?
Answered in the full report
›Is Solvotrin Therapeutics (UK) profitable?
Solvotrin Therapeutics (UK)'s profit isn't public: small companies may file without a profit and loss account.
›How many people work at Solvotrin Therapeutics (UK)?
Answered in the full report
›Who runs and owns Solvotrin Therapeutics (UK)?
Its directors are Patrick Joseph O'Flynn, George Anthony Walsh, Ian Yates. Its owners are shown to subscribers.
›Where is Solvotrin Therapeutics (UK) based?
Its registered office is The Stable Yard Vicarage Road, Stony Stratford, Milton Keynes, Buckinghamshire, MK11 1BN, in Milton Keynes, Buckinghamshire.
›When was Solvotrin Therapeutics (UK) founded?
Solvotrin Therapeutics (UK) Limited was incorporated on 31 October 2018.
›Is Solvotrin Therapeutics (UK) still trading?
The register lists Solvotrin Therapeutics (UK) Limited as active.